
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18â59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Zhang, Yanjun, Zeng, Gang, Pan, Hongxing, Li, Changgui, Hu, Yaling, Chu, Kai, Han, Weixiao, Chen, Zhen, Tang, Rong, Yin, Weidong, Chen, Xin, Hu, Yuansheng, Liu, Xiaoyong, Jiang, Congbing, Li, Jingxin,Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(20)30843-4
Date:
November, 2020
Fichier:
PDF, 1.44 MB
2020